Dr. Reddy’s Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% is an antihistamine eye drop, indicated for the temporary relief of itchy eyes due to pollen, ragweed, grass, animal hair and dander
It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
The approval granted with zero supplementation requests is an important milestone in Glenmark’s respiratory pipeline
Cadila Pharmaceuticals has introduced Dlorfast-M-Tablets as a dual-action therapy that targets two key pathways of allergic response
The portfolio acquired includes Stugeron brand as well as its leading local brands STUGERON FORTE and STUGERON PLUS across 18 markets in the APAC and EMEA regions
A triple-action Formula for comprehensive respiratory relief
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
Subscribe To Our Newsletter & Stay Updated
